by The Global Targeted Drug Delivery Market Is Estimated To Be Valued At US$ 761.95 Mn Or Million In 2023 And Is Expected To Exhibit A CAGR Of 15% Over The Forecast Period 2023 To 2030, As Highlighted In A New Report Published By Coherent Market Insights.
Market Overview:
Targeted Drug Delivery Helps In Delivering Drugs Directly To The Tumor Site Or Affected Part Of The Body, Resulting In Improved Efficacy And Less Systemic Side Effects Compared To Conventional Drugs. This Technique Uses Carriers Such As Liposomes, Micelles, Nanoparticles, And Antibodies To Deliver The Drug To The Targeted Organ/Tissue.
Market Key Trends:
Nanomedicine Is Emerging As One Of The Major Trends In The Targeted Drug Delivery Market. Nanomedicines Enhance The Delivery Of Therapeutic And Diagnostic Agents To Specific Sites In The Body Using Nano-Sized Particles, Tubes, And Spheres. Use Of Nanomaterials Helps Reduce Toxicity And Increases Solubility And Bioavailability Of Drugs. For Example, Liposomes-Mediated Delivery Has Shown Improved Efficacy And Reduced Toxicity For Anticancer Drugs Like Doxorubicin, Daunorubicin, And Mitoxantrone. Also, Polymeric Nanoparticles Facilitate Sustained And Controlled Delivery Of Anticancer Drugs.
Segment Analysis
The Targeted Drug Delivery Market Is Segmented Into Route Of Administration And Application. Based On Route Of Administration, The Market Is Segmented Into Oral, Pulmonary, Injectable, Ocular, Nasal, And Topical. The Injectable Segment Dominated The Market In 2022 Due To Increasing Demand For Monoclonal Antibodies For Treating Various Chronic Disorders Like Cancer. Based On Application, The Market Is Segmented Into Infectious Diseases, Ophthalmology, Oncology, Cardiovascular Diseases, Autoimmune Diseases, Neurological Disorders, And Respiratory Disorders. The Oncology Segment Is Expected To Be The Fastest-Growing Segment During The Forecast Period Due To Rising Prevalence Of Cancer Globally.
Key Takeaways
The Global Targeted Drug Delivery Market Size Is Expected To Witness High Growth, Exhibiting A CAGR Of 15% Over The Forecast Period, Due To Increasing Need For Minimally Invasive Drug Administration.
Regional Analysis – North America Dominated The Global Market In 2022 Owing To Presence Of Key Market Players, Developed Healthcare Infrastructure, And Growing Research Activities In The Region. Asia Pacific Is Expected To Witness The Highest CAGR During The Forecast Period Due To Growth Of The Pharmaceutical And Biotech Industries And Increasing Healthcare Spending In Countries Like China And India.
Key Players – Key Players Operating In The Targeted Drug Delivery Market Are Abbvie Inc., Ablynx NV By Sanofi SA, Arrowhead Pharmaceuticals, Inc., Baxter International Inc., Astrazeneca PLC, Boston Scientific Corporation, Becton, Depomed, Inc., Fraunhofer Gesellschaft Munchen, Janssen Global Services, LLC., Luye Pharma Group, Pfizer Inc., Quark Pharmaceuticals Inc., Rexahn Pharmaceuticals Inc., Savara Inc., Roche Holding AG, Suda Limited, Vectura Group PLC, Taiwan Liposome Company, Ltd., And 3M Company.
*Note:
1. Source: Coherent Market Insights, Public sources, Desk research
2. We have leveraged AI tools to mine information and compile it
Money Singh is a seasoned content writer with over four years of experience in the market research sector. Her expertise spans various industries, including food and beverages, biotechnology, chemicals and materials, defense and aerospace, consumer goods, etc.
